LI
AMED

Leeward Investments’s Amedisys AMED Stock Holding History

Leeward Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-102,789
Closed -$9.47M – 146
2024
Q1 		$9.47M Sell
102,789
-56,127
-35% -$5.26M 0.42% 119
2023
Q4 		$15.1M Sell
158,916
-1,359
-0.8% -$127K 0.71% 57
2023
Q3 		$15M Sell
160,275
-12,163
-7% -$1.12M 0.77% 48
2023
Q2 		$15.8M Sell
172,438
-1,612
-0.9% -$132K 0.74% 48
2023
Q1 		$12.8M Buy
174,050
+36,233
+26% +$3.13M 0.58% 87
2022
Q4 		$11.5M Sell
137,817
-6,274
-4% -$566K 0.51% 97
2022
Q3 		$13.9M Buy
144,091
+54,339
+61% +$6.48M 0.66% 66
2022
Q2 		$9.44M Buy
+89,752
New +$11.5M 0.43% 108

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Leeward Investments's AMED Position: Q2 2024 in Review

Leeward Investments sold out of Amedisys (AMED) in Q2 2024, closing a stake of 102,789 shares — an estimated $9.47M sold.

Leeward Investments first reported a position in AMED in Q2 2022 and held it in 8 quarters. The position peaked at $15.8M in Q2 2023. 289 funds tracked by Wall St. Rank hold AMED as of Q2 2024.

  • Leeward Investments reported no remaining Amedisys position as of Q2 2024 after selling out during the quarter.
  • Leeward Investments sold 102,789 Amedisys shares in Q2 2024, an estimated $9.47M.
  • Leeward Investments first reported a position in Amedisys in Q2 2022 and held it in 8 quarters.
  • Leeward Investments's Amedisys position peaked at $15.8M in Q2 2023.
  • 289 funds tracked by Wall St. Rank held Amedisys as of Q2 2024.

Based on Leeward Investments's 13F filing for Q2 2024, filed 19 Jul 2024.